共 137 条
[1]
Ljungberg B(2015)Guidelines on renal cell carcinoma Eur Urol 67 913-924
[2]
Bensalah K(2014)ESMO Guidelines Working Group. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 25 49-56
[3]
Canfield S(2012)Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer Biologics 6 395-407
[4]
Dabestani S(2015)FDG and FLT-PET for early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma Cancer Imaging 15 15-219
[5]
Hofmann F(2011)Assessment of therapeutic effect of sunitinib by Nucl Med Mol Imaging 45 217-446
[6]
Hora M(2010)C-Acetate PET compared with FDG PET imaging in a patient with metastatic renal cell carcinoma Ann Nucl Med 24 441-277
[7]
Escudier B(2017)Initial experience with Nagoya J Med Sci 79 273-1055
[8]
Porta C(2011)F-fluoroethylcholine PET/CT in staging and monitoring therapy response of advanced renal cell carcinoma J Nucl Med 52 1048-438
[9]
Schmidinger M(2009)C-Choline positive but Mol Imaging Biol 11 434-378
[10]
Algaba F(2017)F-FDG negative pancreatic metastasis from renal cell carcinoma on PET J Med Imaging Radiat Oncol 61 372-10162